The public nature of science may lead to the simplistic conclusion that firms can at no cost avail of the scientific knowledge generated by academia or other non-profit institutions. This paper offers empirical evidence that in-house scientific research raises the ability of the firms to take advantage of "public" science. Case studies of a few large US drug manufacturers show that firms with better in-house scientific research programs have exploited more effectively outside scientific information. Statistical analysis reinforces this conclusion. Using data on the 14 largest US-based drug manufacturers between 1973 and 1986, I find that company patents are positively correlated with the scientific publications of the firms even after controlling for the scale of R&D. © 1992.

Competitive advantages from in-house scientific research: The US pharmaceutical industry in the 1980s

GAMBARDELLA, ALFONSO
1992

Abstract

The public nature of science may lead to the simplistic conclusion that firms can at no cost avail of the scientific knowledge generated by academia or other non-profit institutions. This paper offers empirical evidence that in-house scientific research raises the ability of the firms to take advantage of "public" science. Case studies of a few large US drug manufacturers show that firms with better in-house scientific research programs have exploited more effectively outside scientific information. Statistical analysis reinforces this conclusion. Using data on the 14 largest US-based drug manufacturers between 1973 and 1986, I find that company patents are positively correlated with the scientific publications of the firms even after controlling for the scale of R&D. © 1992.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11565/50950
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 256
  • ???jsp.display-item.citation.isi??? 227
social impact